The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

17 articles for C Fernandes


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Dual protein farnesyltransferase-geranylgeranyltransferase-I inhibitors as potential cancer chemotherapeutic agents.EBI
Merck Research Laboratories
Design and synthesis of chromone-based monoamine oxidase B inhibitors with improved drug-like properties.EBI
University of Porto
Kinesin spindle protein (KSP) inhibitors. Part 3: synthesis and evaluation of phenolic 2,4-diaryl-2,5-dihydropyrroles with reduced hERG binding and employment of a phosphate prodrug strategy for aqueous solubility.EBI
Merck Research Laboratories
Potent 2-[(pyrimidin-4-yl)amine}-1,3-thiazole-5-carbonitrile-based inhibitors of VEGFR-2 (KDR) kinase.EBI
Merck Research Laboratories
Macrocyclic piperazinones as potent dual inhibitors of farnesyltransferase and geranylgeranyltransferase-I.EBI
Merck Research Laboratories
4-Oxoquinolines and monoamine oxidase: When tautomerism matters.EBI
Universit£"Magna Gr£Cia" Di Catanzaro
Mapping Chromone-3-Phenylcarboxamide Pharmacophore: EBI
Magna Graecia University of Catanzaro
The synthesis and biological evaluation of a series of potent dual inhibitors of farnesyl and geranyl-Geranyl protein transferases.EBI
Merck Research Laboratories
Potent inhibitors of farnesyltransferase and geranylgeranyltransferase-I.EBI
Merck Research Laboratories
Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency.EBI
Merck Research Laboratories
Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferase.EBI
Merck Research Laboratories
Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors.EBI
University of Porto
Design of novel monoamine oxidase-B inhibitors based on piperine scaffold: Structure-activity-toxicity, drug-likeness and efflux transport studies.EBI
University of Porto
CGRP receptor antagonistsBDB
Heptares Therapeutics
Amide derivatives and pharmaceutically acceptable salts thereof, preparation method thereof and medicinal application thereofBDB
Jiangsu Hengrui Medicine
Equilibrium thermodynamics of a physiologically-relevant heme-protein complex.BDB
University of North Carolina at Chapel Hill
Calorimetric investigation of ethidium and netropsin binding to chicken erythrocyte chromatin.BDB
Universite De Liege